Nutex Health (NASDAQ:NUTX) Trading Down 7.1% – Should You Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s share price was down 7.1% on Wednesday . The company traded as low as $164.00 and last traded at $169.23. Approximately 51,367 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 151,826 shares. The stock had previously closed at $182.23.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Nutex Health in a report on Monday. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health Stock Performance

The company has a quick ratio of 3.18, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. The firm has a 50-day simple moving average of $141.06 and a 200 day simple moving average of $115.56. The company has a market cap of $1.18 billion, a price-to-earnings ratio of 9.01 and a beta of -0.03.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 EPS for the quarter, beating the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The business had revenue of $243.99 million during the quarter, compared to analysts’ expectations of $221.93 million.

Insider Activity at Nutex Health

In related news, CFO Jon Christian Bates acquired 750 shares of the company’s stock in a transaction that occurred on Tuesday, November 25th. The stock was purchased at an average price of $136.71 per share, for a total transaction of $102,532.50. Following the transaction, the chief financial officer owned 5,638 shares in the company, valued at $770,770.98. This trade represents a 15.34% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 36.92% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Nutex Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Pertento Partners LLP purchased a new position in shares of Nutex Health during the third quarter valued at approximately $27,940,000. Topline Capital Management LLC increased its stake in Nutex Health by 80.0% in the third quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock valued at $57,505,000 after purchasing an additional 247,436 shares during the last quarter. Marshall Wace LLP lifted its position in Nutex Health by 333.4% during the second quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock worth $11,770,000 after buying an additional 72,734 shares during the period. Millennium Management LLC grew its holdings in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after buying an additional 61,308 shares during the period. Finally, Divisadero Street Capital Management LP acquired a new position in shares of Nutex Health during the 2nd quarter valued at about $7,481,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.